Stereotactic radiotherapy is a fundamental change from the conventional fractionated radiotherapy and represents a new therapeutic indication. Stereotactic radiotherapy is now a standard of care for inoperable patients or patients who refuse surgery. The results are encouraging with local control and survival rates very high in selected populations. The rate of late toxicity remains acceptable. Good tolerability makes it appropriate even for elderly and frail patients. In these fragile patients or in certain specific clinical situations, different surgical, radiotherapy or interventional radiology attitudes can be discussed on a case-by-case basis. These situations are considered in this article for the pulmonary, hepatic and prostatic localizations.
Keywords: Cancer de la prostate; Cancer du foie; Cancer du poumon; Chirurgie mini-invasive; Hepatic cancer; Interventional radiology; Lung cancer; Minimally invasive surgery; Prostate cancer; Radiofréquence; Radiothérapie stéréotaxique; Stereotactic radiotherapy.
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.